作者：
Malin,Hultcrantz [1]
;
Hani,Hassoun [2]
;
Neha,Korde [2]
;
Kylee,MacLachlan [2]
;
Sham,Mailankody [2]
;
Dhwani,Patel [2]
;
Urvi A,Shah [2]
;
Carlyn Rose,Tan [2]
;
David J,Chung [3]
;
Oscar B,Lahoud [3]
;
Heather J,Landau [3]
;
Michael,Scordo [3]
;
Gunjan L,Shah [3]
;
Sergio A,Giralt [3]
;
Matthew J,Pianko [4]
;
Miranda,Burge [2]
;
Kelly,Barnett [2]
;
Meghan,Salcedo [2]
;
Julia,Caple [2]
;
Linh,Tran [2]
;
Jenna,Blaslov [2]
;
Tala,Shekarkhand [2]
;
Selena,Hamid [2]
;
David,Nemirovsky [5]
;
Andriy,Derkach [5]
;
Oluwatobi,Arisa [6]
;
Cody J,Peer [6]
;
William D,Figg [6]
;
Saad Z,Usmani [2]
;
Ola,Landgren [7]
;
Alexander M,Lesokhin [2]
作者单位：
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hultcram@mskcc.org.
[1]
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[2]
Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[3]
Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
[4]
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[5]
Clinical Pharmacology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[6]
Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
[7]
DOI
10.1038/s41408-024-01136-1
PMID
39300066
发布时间
2024-11-07
换一批
换一批
